The Wall Street Journal: Adamis Pharma stock jumps after FDA agrees to review injectable opioid-overdose treatment

Original post

Adamis Pharmaceuticals Corp. said the U.S. Food and Drug Administration has accepted for review its New Drug Application for a naloxone injection product used to treat opioid overdoses.